Related Experiment Video
Updated: Jun 2, 2026

A Three-Dimensional Spheroid Model to Investigate the Tumor-Stromal Interaction in Hepatocellular Carcinoma
Published on: September 30, 2021
Impact of hepatitis C in mortality in patients on hemodialysis
Cristian Paul Leon Rabanal1, Javier Cieza Zevallos, Roberto Cieza Cusato
1Universidad Peruana Cayetano Heredia. cristianleonr27@hotmail.com
Insights
Hepatitis C infection did not increase mortality risk in patients undergoing hemodialysis. Survival rates were unexpectedly better for hepatitis C-infected patients compared to uninfected patients in this cohort study.
Area of Science:
- Nephrology
- Infectious Diseases
- Epidemiology
Background:
- Cardiovascular diseases are a primary cause of mortality in end-stage renal disease (ESRD) patients.
- Viral infections, particularly hepatitis B and C, significantly impact survival and morbidity in hemodialysis patients.
- Understanding the specific impact of hepatitis C on hemodialysis patient mortality is crucial.
Purpose of the Study:
- To assess the influence of hepatitis C infection on the mortality rates of patients undergoing hemodialysis.
- To investigate the relationship between hepatitis C and survival in ESRD patients on hemodialysis.
Main Methods:
- A non-concurrent cohort study design was employed.
- The study followed two cohorts of 74 patients each over a ten-year period.
- Statistical analysis, including Cox-Mantel log-rank test, was used to compare survival rates.
Main Results:
- Hepatitis C infection was not associated with an increased risk of death.
- Patients infected with hepatitis C demonstrated better survival rates than uninfected patients.
- One-year and five-year survival rates were 95.5% and 73.1% for hepatitis C-infected patients, versus 93.9% and 52.3% for non-infected patients (p = 0.02).
Conclusions:
- Hepatitis C infection does not correlate with increased mortality in hemodialysis patients with ESRD.
- The study found no increased mortality risk associated with hepatitis C in this patient population.
- Survival outcomes were unexpectedly favorable in hepatitis C-infected hemodialysis patients.
Objective:
Cardiovascular diseases are the most important causes of mortality in patients with end-stage renal disease. However, viral infections (hepatitis B and C) have acquired great importance for patients undergoing hemodialysis, because they affect patients' survival and increase morbidity and mortality. This study aimed at assessing the influence of hepatitis C on the mortality of patients undergoing hemodialysis.
Methods:
This is a non-concurrent cohort study during a period of ten years.
Results:
Each cohort comprised 74 patients. Hepatitis C did not increase the risk of death, and the survival of infected patients was better than that of patients without hepatitis C. The one-year and five-year survivals of non-infected patients were 93.9% and 52.3%, respectively, while those of noninfected patients were 95.5% and 73.1%, respectively (Cox-Mantel log-rank, p = 0.02).
Conclusion:
No increase in mortality risk was observed. Hepatitis C did not correlate with an increase in mortality in patients with end-stage renal disease undergoing hemodialysis.
Related Concept Videos
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow
Hemodialysis II: Procedure and Complications
Hepatitis
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment
Hemodialysis III: Nursing Management